Bulletin from Extraordinary General Meeting in Smart Eye Aktiebolag (publ)
Smart Eye (STO:SEYE)(OTC PINK:SMTEF) held an Extraordinary General Meeting (EGM) on December 30, 2022, where shareholders authorized the Board of Directors to issue new shares without deviating from shareholders' preferential rights. This authorization aims to facilitate a rights issue previously announced on December 5, 2022. The share price for the new issuance will be determined based on market conditions with standard discounts. The meeting underscores Smart Eye's strategy to enhance its capital structure.
- Authorization for new share issues enhances capital availability for growth.
- Previous announcements indicate strategic fundraising efforts.
- None.
GÖTEBORG, SE / ACCESSWIRE / December 30, 2022 / Smart Eye (STO:SEYE)(OTC PINK:SMTEF)(FRA:SE9) The following resolutions were passed at the Extraordinary General Meeting (the "EGM") of Smart Eye Aktiebolag (publ) ("Smart Eye" or the "Company") held today, on 30 December 2022.
Resolution to authorise the Board of Directors to resolve on new share issues
The EGM resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors, within the current articles of association, for the period until the end of the next Annual General Meeting, resolve on new share issue without deviation from the shareholders' preferential rights. The purpose of the authorisation is for the Company to be able to implement the rights issue announced by the Company on 5 December 2022. The subscription price shall be determined on market terms and conditions with customary issue discount.
For more information, please contact:
Martin Krantz, CEO, Smart Eye
Telephone: +46 70-329 26 98
Email: martin.krantz@smarteye.se.
The information was submitted for publication, through the agency of the contact person set out above, at 6 PM CET on 30 December 2022.
About Smart Eye
Smart Eye is the global leader in Human Insight AI, technology that understands, supports, and predicts human behavior in complex environments. We are bridging the gap between humans and machines for a safe and sustainable future. Our multimodal software and hardware solutions provide unprecedented human insight in automotive and behavioral research-supported also by Affectiva and iMotions, companies we acquired in 2021.
In automotive, we are leading the way towards safer and human-centric mobility through Driver Monitoring Systems and Interior Sensing solutions. Our technology is embedded in next-generation vehicles and available as a standalone aftermarket solution for existing vehicles, fleet, and small-volume OEMs.
Our industry-leading eye tracking systems and iMotions biosensor software enable advanced research and training in academic and commercial sectors. Affectiva's Emotion AI provides the world's largest brands and market researchers with a deeper understanding of how consumers engage with their content, products, and services.
Smart Eye was founded in 1999 and is headquartered in Sweden with offices in the US, UK, Germany, Denmark, Egypt, Singapore, China and Japan. A publicly traded company since 2016, our customers include NASA, Nissan, Boeing, Honeywell, Volvo, GM, BMW, Geely, Harvard University, over 1,300 research organizations around the world,
Visit www.smarteye.ai for more information.
Visit our investor web for more financial information: https://smarteye.se/investors/.
Smart Eye is listed on Nasdaq First North Growth Market. Erik Penser is Certified Adviser.
Attachments
Bulletin from Extraordinary General Meeting in Smart Eye Aktiebolag (publ)
SOURCE: Smart Eye
View source version on accesswire.com:
https://www.accesswire.com/733668/Bulletin-from-Extraordinary-General-Meeting-in-Smart-Eye-Aktiebolag-publ
FAQ
What happened at Smart Eye's Extraordinary General Meeting on December 30, 2022?
What is the purpose of the new share issue authorized by Smart Eye?
What will determine the subscription price for Smart Eye's new shares?
How does the new share issue impact Smart Eye's shareholders?
